Skip to Main Content
(215) 567-3500

Call Us, We Can Help.

CMS proposal limits coverage of drug to help diagnose Alzheimer’s.

On Wednesday, the Centers for Medicare & Medicaid Services proposed that “Medicare will pay the costs of brain imaging that uses a Eli Lilly & Co. drug to help diagnose Alzheimer’s disease only for patients participating in approved clinical studies,” Bloomberg News (7/4, Lopatto) reported. According to regulators, “there isn’t enough evidence to show […]

https://www.chrisplacitella.com/2013/07/07/cms-proposal-limits-coverage-of-drug-to-help-diagnose-alzheimers/

Brought to you by:

CPR Law

2001 Market Street, Suite 2900
Philadelphia,
Pennsalvania
19103

Phone: (215) 567-3500

Contact us for your consultation (215) 567-3500

Site By: